Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Your support goes further this holiday season. When you buy an annual membership or give a one-time contribution, we’ll give a membership to someone who can’t afford access. It’s a simple way for you ...

We independently review everything we recommend. We may make money from the links on our site. Learn more› By Samantha Schoech and Mari Uyehara The clock is ticking to buy Christmas gifts, but you ...

Getting good at LeetCode Java isn’t just about solving problems; it’s about having a good plan. You need to know where to ...